Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1998 Jan;91(1):32–34. doi: 10.1177/014107689809100111

Breast cancer after radiotherapy for Hodgkin's disease.

G Mitchell 1, A Horwich 1
PMCID: PMC1296423  PMID: 9536140

Full text

PDF
32

Images in this article

33Figure 1
on p.33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bhatia S., Robison L. L., Oberlin O., Greenberg M., Bunin G., Fossati-Bellani F., Meadows A. T. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 1996 Mar 21;334(12):745–751. doi: 10.1056/NEJM199603213341201. [DOI] [PubMed] [Google Scholar]
  2. Bonadonna G., Valagussa P., Moliterni A., Zambetti M., Brambilla C. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer: the results of 20 years of follow-up. N Engl J Med. 1995 Apr 6;332(14):901–906. doi: 10.1056/NEJM199504063321401. [DOI] [PubMed] [Google Scholar]
  3. Cimino G., Papa G., Tura S., Mazza P., Rossi Ferrini P. L., Bosi A., Amadori S., Lo Coco F., D'Arcangelo E., Giannarelli D. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study. J Clin Oncol. 1991 Mar;9(3):432–437. doi: 10.1200/JCO.1991.9.3.432. [DOI] [PubMed] [Google Scholar]
  4. Dionet C., Oberlin O., Habrand J. L., Vilcoq J., Madelain M., Dutou L., Bey P., Lefur R., Thierry P., Le Floch O. Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris. Int J Radiat Oncol Biol Phys. 1988 Aug;15(2):341–346. doi: 10.1016/s0360-3016(98)90013-x. [DOI] [PubMed] [Google Scholar]
  5. Hancock S. L., Tucker M. A., Hoppe R. T. Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst. 1993 Jan 6;85(1):25–31. doi: 10.1093/jnci/85.1.25. [DOI] [PubMed] [Google Scholar]
  6. Hancock SL, Hoppe RT. Long-Term Complications of Treatment and Causes of Mortality After Hodgkin's Disease. Semin Radiat Oncol. 1996 Jul;6(3):225–242. doi: 10.1053/SRAO00600225. [DOI] [PubMed] [Google Scholar]
  7. Rodriguez M. A., Fuller L. M., Zimmerman S. O., Allen P. K., Brown B. W., Munsell M. F., Hagemeister F. B., McLaughlin P., Velasquez W. S., Swan F., Jr Hodgkin's disease: study of treatment intensities and incidences of second malignancies. Ann Oncol. 1993 Feb;4(2):125–131. doi: 10.1093/oxfordjournals.annonc.a058414. [DOI] [PubMed] [Google Scholar]
  8. Swerdlow A. J., Barber J. A., Horwich A., Cunningham D., Milan S., Omar R. Z. Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. Br J Cancer. 1997;75(1):116–123. doi: 10.1038/bjc.1997.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Swerdlow A. J., Douglas A. J., Hudson G. V., Hudson B. V., Bennett M. H., MacLennan K. A. Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. BMJ. 1992 May 2;304(6835):1137–1143. doi: 10.1136/bmj.304.6835.1137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Tucker M. A., Coleman C. N., Cox R. S., Varghese A., Rosenberg S. A. Risk of second cancers after treatment for Hodgkin's disease. N Engl J Med. 1988 Jan 14;318(2):76–81. doi: 10.1056/NEJM198801143180203. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES